[1] World Health Organization. Novel coronavirus-China [EB/OL]. (2020-01-12)[2020-03-16]. https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/. [2] World Health Organization. WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February, 2020[EB/OL]. (2020-02-11)[2020-03-16]. https://www.who.int/dg/speeches/detail/WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February, 2020. [3] 湖南省人民政府.湖南省决定启动重大突发公共卫生事件一级响应[EB/OL].(2020-01-24)[2020-03-16]. http://www.hunan.gov.cn/hnszf/hnyw/sy/hnyw1/202001/t20200124_11164086.html. [4] Zhou P,Yang XL,Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin[J]. Nature,2020,579(7798):270-273. [5] Paraskevis D, Kostaki EG, Magiorkinis G,et al.Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event[J].Infect Genet Evol,2020,79:104212. [6] 国家卫生健康委员会.新型冠状病毒肺炎防控方案(试行第七版)[Z]. 2020-03-04. [7] 中华人民共和国国家质量监督检验检疫总局,中国国家标准化管理委员会. 风险管理 原则与实施指南:GB/T 24353-2009[S].北京:中国标准出版社,2009:1-15. [8] 中国合格评定国家认可委员会. CNAS-CL01 检测和校准实验室能力认可准则[S/OL].[2012-12-18].https://www.cnas.org.cn/sysrk/syskgf/rkzz/12/719635.shtml. [9] 中国合格评定国家认可委员会.CNAS-CL01-A001 检测和校准实验室能力认可准则 在微生物检测领域的应用说明[S/OL]. [2018-03-01].https://www.cnas.org.cn/rkgf/sysrk/rkyyzz/2018/03/889076.shtml. [10] 谢荣珍,林健,柯素容.基于国家认可委通报的问题浅谈实验室风险识别和管控[J].海峡预防医学杂志,2019,25(4):92-94. [11] 郎楠,袁媛,周静.防控新型冠状病毒肺炎医用个体防护装备国内外标准的比较[J].职业卫生与应急救援,2020,38(2):1-4. [12] 施绍瑞,聂滨,郭渝,等.新型冠状病毒肺炎病例多种生物样本的病毒核酸检测结果[J].华西医学,2020,35(2):132-136. [13] 中华人民共和国国家质量监督检验检疫总局,中国国家标准化管理委员会. 实验室 生物安全通用要求:GB 19489-2008[S]. 北京:中国标准出版社,2008. [14] 中华人民共和国住房和城乡建设部,中华人民共和国国家质量监督检验检疫总局. 生物安全实验室建筑技术规范:GB 50346-2011[S]. 北京:中国建筑工业出版社,2011:1-20. [15] Zhang Y,Gong Y,Wang C,et al. Rapid deployment of a mobile biosafety level-3 laboratory in Sierra Leone during the 2014 Ebola virus epidemic[J]. PLoS Negl Trop Dis,2017,11(5):e0005622. [16] 中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组.新型冠状病毒肺炎流行病学特征分析[J].中华流行病学杂志,2020,41(2):145-151. [17] Zumla A,Hui DS,Perlman S. Middle East respiratory syndrome[J]. Lancet,2015,386(9997): 995-1007. [18] Hui DSC,Zumla A. Severe acute respiratory syndrome: historical,epidemiologic,and clinical features.[J]. Infect Dis Clin North Am,2019,33(4):869-889. [19] Zhao S,Lin Q,Ran J,et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak[J]. Int J Infect Dis,2020,92:214-217. [20] Wu JT,Leung K,Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan,China: a modelling study[J]. Lancet,2020,395(10225):689-697. [21] 姜孟楠,王嘉琪,刘波,等. 全国省级卫生行政主管部门实验室生物安全管理能力调查及分析[J]. 疾病监测,2016,31(2):166-170. [22] Wurtz N,Papa A,Hukic M,et al. Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories[J]. Eur J Clin Microbiol Infect Dis,2016,35(8):1247-1258. [23] 郑玉红,侯雪新,李振军. 生物安全培训问题分析及系统培训方法建立的研究[J]. 实用预防医学,2015,22(6):760-762. [24] Weiss S,Yitzhaki S,Shapira SC.Lessons to be learned from recent biosafety incidents in the United States[J].Isr Med Assoc J,2015,17(5):269-273.
2021, Vol. 28 
